HIGH-INCIDENCE OF CARDIOMYOPATHY IN BETA-THALASSEMIA PATIENTS RECEIVING REGULAR TRANSFUSION AND IRON CHELATION - REVERSAL BY INTENSIFIED CHELATION

被引：1
|
作者：
ALDOURI, MA
WONKE, B
HOFFBRAND, AV
FLYNN, DM
WARD, SE
AGNEW, JE
HILSON, AJW
机构：
[1] ROYAL FREE HOSP,SCH MED,DEPT HAEMATOL,POND ST,LONDON NW3 2QG,ENGLAND
[2] WHITTINGTON HOSP,LONDON,ENGLAND
来源：
ACTA HAEMATOLOGICA | 1990年 / 84卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：113 / 117
页数：5
相关论文
共 50 条
  • [1] REVERSAL OF HAEMOCHROMATOTIC CARDIOMYOPATHY IN BETA-THALASSEMIA BY CHELATION-THERAPY
    POLITI, A
    STICCA, M
    GALLI, M
    [J]. BRITISH HEART JOURNAL, 1995, 73 (05): : 486 - 487
  • [2] Beta-thalassemia and the advent of new interventions beyond transfusion and iron chelation
    Chauhan, Waseem
    Shoaib, Shoaib
    Fatma, Rafat
    Zaka-ur-Rab, Zeeba
    Afzal, Mohammad
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (08) : 3610 - 3626
  • [3] Promoting Adherence to Iron Chelation Treatment in Beta-Thalassemia Patients
    Eziefula, Chinea
    Shah, Farrukh
    Anie, Kofi A.
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2022, 16 : 1423 - 1437
  • [4] EVALUATION OF CARDIAC-FUNCTION IN PATIENTS WITH TRANSFUSION-DEPENDENT BETA-THALASSEMIA AND CHRONIC IRON OVERLOAD RECEIVING CHELATION-THERAPY
    LEON, MB
    BORER, JS
    BACHARACH, SL
    GREEN, MV
    GRIFFITH, P
    ANDERSON, WF
    NIENHUIS, AW
    [J]. CLINICAL RESEARCH, 1980, 28 (02): : A318 - A318
  • [5] Evaluation of the incidence of sensorineural hearing loss in beta-thalassemia major patients under regular chelation therapy with desferrioxamine
    Karimi, M
    Asadi-Pooya, AA
    Khademi, B
    Asadi-Pooya, K
    Yarmohammadi, H
    [J]. ACTA HAEMATOLOGICA, 2002, 108 (02) : 79 - 83
  • [6] Audiological evaluation in adult beta-thalassemia major patients under regular chelation treatment
    Ambrosetti, U
    Dondè, E
    Piatti, G
    Cappellini, MD
    [J]. PHARMACOLOGICAL RESEARCH, 2000, 42 (05) : 485 - 487
  • [7] Renal Dysfunction in Patients with Beta-Thalassemia Major Receiving Iron Chelation Therapy either with Deferoxamine and Deferiprone or with Deferasirox
    Economou, Marina
    Printza, Nikoletta
    Teli, Aikaterini
    Tzimouli, Vassiliki
    Tsatra, Ioanna
    Papachristou, Fotis
    Athanassiou-Metaxa, Miranda
    [J]. ACTA HAEMATOLOGICA, 2010, 123 (03) : 148 - 152
  • [8] Vascular and hemostatic alterations associated with pulmonary hypertension in β-thalassemia hemoglobin E patients receiving regular transfusion and iron chelation
    Uaprasert, Noppacharn
    Satitthummanid, Sudarat
    Akkawat, Benjaporn
    Sutcharitchan, Pranee
    Rojnuckarin, Ponlapat
    [J]. THROMBOSIS RESEARCH, 2019, 174 : 104 - 112
  • [9] Vascular and Hemostatic Alterations Associated with Pulmonary Hypertension in ß-Thalassemia Hemoglobin E Patients Receiving Regular Transfusion and Iron Chelation
    Uaprasert, Noppacharn
    Satitthummanid, Sudarat
    Akkawat, Benjaporn
    Sutcharitchan, Pranee
    Rojnuckarin, Ponlapat
    [J]. BLOOD, 2017, 130
  • [10] HIGH-INCIDENCE OF CHOLELITHIASIS IN OLDER PATIENTS WITH HOMOZYGOUS BETA-THALASSEMIA
    GOLDFARB, A
    GRISARU, D
    GIMMON, Z
    OKON, E
    LEBENSART, P
    RACHMILEWITZ, EA
    [J]. ACTA HAEMATOLOGICA, 1990, 83 (03) : 120 - 122
12345